Paul Campanelli, EVP, Pres-Par Pharmaceutical at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), sold 105,647 shares at $30.67 ($3.2M) on 2011-03-07, disclosed to the SEC on 2011-03-09.
Seasonal sale ($3.2M) by EVP, Pres-Par Pharmaceutical — this insider has traded PRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.65 | 746 | $23K | 0.7% |
| 2 | $30.66 | 300 | $9K | 0.3% |
| 3 | $30.67 | 1,600 | $49K | 1.5% |
| 4 | $30.68 | 400 | $12K | 0.4% |
| 5 | $30.68 | 1,000 | $31K | 0.9% |
| 6 | $30.75 | 75,400 |
| $2.3M |
| 71.3% |
| 7 | $30.76 | 700 | $22K | 0.7% |
| 8 | $30.76 | 4,500 | $138K | 4.3% |
| 9 | $30.76 | 2,300 | $71K | 2.2% |
| 10 | $30.77 | 2,300 | $71K | 2.2% |
| 11 | $30.77 | 3,601 | $111K | 3.4% |
| 12 | $30.78 | 1,300 | $40K | 1.2% |
| 13 | $30.79 | 500 | $15K | 0.5% |
| 14 | $30.80 | 1,300 | $40K | 1.2% |
| 15 | $30.81 | 2,300 | $71K | 2.2% |
| 16 | $30.82 | 1,500 | $46K | 1.4% |
| 17 | $30.83 | 300 | $9K | 0.3% |
| 18 | $30.84 | 100 | $3K | 0.1% |
| 19 | $30.85 | 200 | $6K | 0.2% |
| 20 | $30.86 | 100 | $3K | 0.1% |
| 21 | $30.87 | 200 | $6K | 0.2% |
| 22 | $30.88 | 1,400 | $43K | 1.3% |
| 23 | $30.89 | 1,200 | $37K | 1.1% |
| 24 | $30.90 | 1,200 | $37K | 1.1% |
| 25 | $30.95 | 1,200 | $37K | 1.1% |
| Total | $30.76 avg | 105,647 | $3.2M | 100% |
| Filing → |
| ENDP | BUY | 2016-05-11 | $202K | — | Filing → |
| ENDP | BUY | 2015-11-12 | $117K | — | Filing → |
| PRX | SELL | 2011-03-09 | $1.5M | — | Filing → |